397 related articles for article (PubMed ID: 18619528)
21. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.
Kim EJ; Shim G; Kim K; Kwon IC; Oh YK; Shim CK
J Gene Med; 2009 Sep; 11(9):791-803. PubMed ID: 19569085
[TBL] [Abstract][Full Text] [Related]
22. Functionalization of carbon nanotubes enables non-covalent binding and intracellular delivery of small interfering RNA for efficient knock-down of genes.
Krajcik R; Jung A; Hirsch A; Neuhuber W; Zolk O
Biochem Biophys Res Commun; 2008 May; 369(2):595-602. PubMed ID: 18298946
[TBL] [Abstract][Full Text] [Related]
23. Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery.
Xiong XB; Uludağ H; Lavasanifar A
Biomaterials; 2009 Jan; 30(2):242-53. PubMed ID: 18838158
[TBL] [Abstract][Full Text] [Related]
24. Delivering silence: advancements in developing siRNA therapeutics.
Novobrantseva TI; Akinc A; Borodovsky A; de Fougerolles A
Curr Opin Drug Discov Devel; 2008 Mar; 11(2):217-24. PubMed ID: 18283609
[TBL] [Abstract][Full Text] [Related]
25. Amine-functionalized gold nanoparticles as non-cytotoxic and efficient intracellular siRNA delivery carriers.
Lee SH; Bae KH; Kim SH; Lee KR; Park TG
Int J Pharm; 2008 Nov; 364(1):94-101. PubMed ID: 18723087
[TBL] [Abstract][Full Text] [Related]
26. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
[TBL] [Abstract][Full Text] [Related]
27. Intracellular delivery of oligonucleotide conjugates and dendrimer complexes.
Juliano RL
Ann N Y Acad Sci; 2006 Oct; 1082():18-26. PubMed ID: 17145920
[TBL] [Abstract][Full Text] [Related]
28. Aspects of the transport and delivery of antisense oligonucleotides.
Juliano RL; Yoo H
Curr Opin Mol Ther; 2000 Jun; 2(3):297-303. PubMed ID: 11249624
[TBL] [Abstract][Full Text] [Related]
29. The efficiency of CD40 down regulation by siRNA and antisense ODN: comparison of lipofectamine and FuGENE6.
Ebadi P; Karimi MH; Pourfathollah AA; Saheb Ghadam Lotfi A; Soheili ZS; Samiee S; Hajati S; Nadali F; Geramizadeh B; Moazzeni SM
Iran J Immunol; 2009 Mar; 6(1):1-11. PubMed ID: 19293472
[TBL] [Abstract][Full Text] [Related]
30. Delivery of RNA interference therapeutics using polycation-based nanoparticles.
Howard KA
Adv Drug Deliv Rev; 2009 Jul; 61(9):710-20. PubMed ID: 19356738
[TBL] [Abstract][Full Text] [Related]
31. Comparison of antisense oligonucleotide drug delivery systems.
Weyermann J; Lochmann D; Zimmer A
J Control Release; 2004 Dec; 100(3):411-23. PubMed ID: 15567506
[TBL] [Abstract][Full Text] [Related]
32. Effective intracellular delivery of oligonucleotides in order to make sense of antisense.
Shi F; Hoekstra D
J Control Release; 2004 Jun; 97(2):189-209. PubMed ID: 15196747
[TBL] [Abstract][Full Text] [Related]
33. Tailored design of Au nanoparticle-siRNA carriers utilizing reversible addition-fragmentation chain transfer polymers.
Kirkland-York S; Zhang Y; Smith AE; York AW; Huang F; McCormick CL
Biomacromolecules; 2010 Apr; 11(4):1052-9. PubMed ID: 20337403
[TBL] [Abstract][Full Text] [Related]
34. Systemic delivery and pre-clinical evaluation of nanoparticles containing antisense oligonucleotides and siRNAs.
Zhang C; Newsome JT; Mewani R; Pei J; Gokhale PC; Kasid UN
Methods Mol Biol; 2009; 480():65-83. PubMed ID: 19085118
[TBL] [Abstract][Full Text] [Related]
35. Nanocarriers: a tool to overcome biological barriers in siRNA delivery.
Kumari A; Kumar V; Yadav SK
Expert Opin Biol Ther; 2011 Oct; 11(10):1327-39. PubMed ID: 21682658
[TBL] [Abstract][Full Text] [Related]
36. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides.
Meade BR; Dowdy SF
Adv Drug Deliv Rev; 2007 Mar; 59(2-3):134-40. PubMed ID: 17451840
[TBL] [Abstract][Full Text] [Related]
37. The performance of nanocarriers for transmucosal drug delivery.
Csaba N; Garcia-Fuentes M; Alonso MJ
Expert Opin Drug Deliv; 2006 Jul; 3(4):463-78. PubMed ID: 16822222
[TBL] [Abstract][Full Text] [Related]
38. Intracellular small interfering RNA delivery using genetically engineered double-stranded RNA binding protein domain.
Kim J; Lee SH; Choe J; Park TG
J Gene Med; 2009 Sep; 11(9):804-12. PubMed ID: 19569061
[TBL] [Abstract][Full Text] [Related]
39. Degradable polyethylenimines as DNA and small interfering RNA carriers.
Jere D; Jiang HL; Arote R; Kim YK; Choi YJ; Cho MH; Akaike T; Cho CS
Expert Opin Drug Deliv; 2009 Aug; 6(8):827-34. PubMed ID: 19558333
[TBL] [Abstract][Full Text] [Related]
40. [Drug delivery systems in gene therapy].
Takakura Y
Nihon Rinsho; 1998 Mar; 56(3):691-5. PubMed ID: 9549358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
